Miz1 is a critical repressor of cdkn1a during skin tumorigenesis

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Hönnemann, Jan ^a   Sanz Moreno, Adrián ^a   Wolf, Elmar ^b   Eilers, Martin ^b   Elsässer, Hans Peter ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYCLIN DEPENDENT KINASE INHIBITOR 2B; MYC PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN BCL 6; RAS PROTEIN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MIZ1; UNCLASSIFIED DRUG; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CDKN1A PROTEIN, MOUSE; CDKN2B PROTEIN, MOUSE; MIZ1 PROTEIN, MOUSE; NUCLEAR PROTEIN; PROTEIN INHIBITOR OF ACTIVATED STAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA BINDING; EPIDERMIS; GENE DELETION; GENE FUNCTION; GENE REPRESSION; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PROTEIN DOMAIN; SKIN CARCINOGENESIS; SKIN TUMOR; STEM CELL; ANIMAL; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL NEOPLASM; GENETICS; METABOLISM; PROTEIN TERTIARY STRUCTURE; TRANSGENIC MOUSE;

ANIMALIA;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P21; MICE; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; NUCLEAR PROTEINS; PROTEIN INHIBITORS OF ACTIVATED STAT; PROTEIN STRUCTURE, TERTIARY; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 84859582396     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034885     Document Type: Article

References (49)

1. Peukert K, Staller P, Schneider A, Carmichael G, Hänel F, et al. (1997) An alternative pathway for gene regulation by Myc. EMBO J 16: 5672-5686 doi:10.1093/emboj/16.18.5672.
2. Bardwell VJ, Treisman R, (1994) The POZ domain: a conserved protein-protein interaction motif. Genes Dev 8: 1664-1677.
3. Stead MA, Trinh CH, Garnett JA, Carr SB, Baron AJ, et al. (2007) A beta-sheet interaction interface directs the tetramerisation of the Miz-1 POZ domain. J Mol Biol 373: 820-826 doi:10.1016/j.jmb.2007.08.026.
4. Stogios PJ, Downs GS, Jauhal JJS, Nandra SK, Privé GG, (2005) Sequence and structural analysis of BTB domain proteins. Genome Biol 6: R82 doi:10.1186/gb-2005-6-10-r82.
5. Möröy T, Saba I, Kosan C, (2011) The role of the transcription factor Miz-1 in lymphocyte development and lymphomagenesis-Binding Myc makes the difference. Semin Immunol 23: 379-387 doi:10.1016/j.smim.2011.09.001.
6. Kosan C, Saba I, Godmann M, Herold S, Herkert B, et al. (2010) Transcription factor miz-1 is required to regulate interleukin-7 receptor signaling at early commitment stages of B cell differentiation. Immunity 33: 917-928 doi:10.1016/j.immuni.2010.11.028.
7. Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, et al. (2001) TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol 3: 400-408 doi:10.1038/35070086.
8. Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, et al. (2001) Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol 3: 392-399 doi:10.1038/35070076.
9. Herold S, Wanzel M, Beuger V, Frohme C, Beul D, et al. (2002) Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol Cell 10: 509-521.
10. Kime L, Wright SC, (2003) Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc. Biochem J 370: 291-298 doi:10.1042/BJ20021679.
11. Patel JH, McMahon SB, (2007) BCL2 is a downstream effector of MIZ-1 essential for blocking c-MYC-induced apoptosis. J Biol Chem 282: 5-13 doi:10.1074/jbc.M609138200.
12. Gebhardt A, Frye M, Herold S, Benitah SA, Braun K, et al. (2006) Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1. J Cell Biol 172: 139-149 doi:10.1083/jcb.200506057.
13. Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R, (2005) BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol 6: 1054-1060 doi:10.1038/ni1245.
14. Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, et al. (2003) Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22: 351-360 doi:10.1038/sj.onc.1206145.
15. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, et al. (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250.
16. Basu S, Liu Q, Qiu Y, Dong F, (2009) Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1. Proc Natl Acad Sci USA 106: 1433-1438 doi:10.1073/pnas.0804863106.
17. Liu J, Zhao Y, Eilers M, Lin A, (2009) Miz1 is a signal- and pathway-specific modulator or regulator (SMOR) that suppresses TNF-alpha-induced JNK1 activation. Proc Natl Acad Sci USA 106: 18279-18284 doi:10.1073/pnas.0906328106.
18. Adhikary S, Peukert K, Karsunky H, Beuger V, Lutz W, et al. (2003) Miz1 is required for early embryonic development during gastrulation. Mol Cell Biol 23: 7648-7657.
19. Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W, (2001) beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105: 533-545.
20. Gebhardt A, Kosan C, Herkert B, Möröy T, Lutz W, et al. (2007) Miz1 is required for hair follicle structure and hair morphogenesis. J Cell Sci 120: 2586-2593 doi:10.1242/jcs.007104.
21. Möröy T, Saba I, Kosan C, (2011) The role of the transcription factor Miz-1 in lymphocyte development and lymphomagenesis-Binding Myc makes the difference. Semin Immunol Available:http://www.ncbi.nlm.nih.gov/pubmed/22000024. Accessed 3 November 2011.
22. Oskarsson T, Essers MAG, Dubois N, Offner S, Dubey C, et al. (2006) Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene. Genes Dev 20: 2024-2029 doi:10.1101/gad.381206.
23. Bickenbach JR, (1981) Identification and behavior of label-retaining cells in oral mucosa and skin. J Dent Res 60 Spec No C: 1611-1620.
24. Yuspa SH, Hennings H, Lichti U, (1981) Initiator and promoter induced specific changes in epidermal function and biological potential. J Supramol Struct Cell Biochem 17: 245-257 doi:10.1002/jsscb.380170306.
25. Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E, (2004) Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 118: 635-648 doi:10.1016/j.cell.2004.08.012.
26. Morris RJ, Liu Y, Marles L, Yang Z, Trempus C, et al. (2004) Capturing and profiling adult hair follicle stem cells. Nat Biotechnol 22: 411-417 doi:10.1038/nbt950.
27. Yuspa SH, Hawley-Nelson P, Koehler B, Stanley JR, (1980) A Survey of Transformation Markers in Differentiating Epidermal Cell Lines in Culture. Cancer Research 40: 4694-4703.
28. Ridd K, Dhir S, Smith AG, Gant TW, (2010) Defective TPA signalling compromises HaCat cells as a human in vitro skin carcinogenesis model. Toxicol In Vitro 24: 910-915 doi:10.1016/j.tiv.2009.11.017.
29. Kemp CJ, (2005) Multistep skin cancer in mice as a model to study the evolution of cancer cells. Semin Cancer Biol 15: 460-473 doi:10.1016/j.semcancer.2005.06.003.
30. Nagase H, Mao J-H, Balmain A, (2003) Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice. Cancer Res 63: 4849-4853.
31. Topley GI, Okuyama R, Gonzales JG, Conti C, Dotto GP, (1999) p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. Proc Natl Acad Sci USA 96: 9089-9094.
32. Weinberg WC, Denning MF, (2002) p21WAF1 Control of Epithelial Cell Cycle and Cell Fate. Critical Reviews in Oral Biology & Medicine 13: 453-464 doi:10.1177/154411130201300603.
33. Wanzel M, Herold S, Eilers M, (2003) Transcriptional repression by Myc. Trends Cell Biol 13: 146-150.
34. Wanzel M, Russ AC, Kleine-Kohlbrecher D, Colombo E, Pelicci P-G, et al. (2008) A ribosomal protein L23-nucleophosmin circuit coordinates Mizl function with cell growth. Nat Cell Biol 10: 1051-1061.
35. Herkert B, Dwertmann A, Herold S, Abed M, Naud J-F, et al. (2010) The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis. J Cell Biol 188: 905-918 doi:10.1083/jcb.200908103.
36. Miao L, Song Z, Jin L, Zhu YM, Wen LP, et al. (2010) ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation. Oncogene 29: 711-722 doi:10.1038/onc.2009.372.
37. Zanet J, Pibre S, Jacquet C, Ramirez A, de Alborán IM, et al. (2005) Endogenous Myc controls mammalian epidermal cell size, hyperproliferation, endoreplication and stem cell amplification. J Cell Sci 118: 1693-1704 doi:10.1242/jcs.02298.
38. van Riggelen J, Müller J, Otto T, Beuger V, Yetil A, et al. (2010) The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance. Genes Dev 24: 1281-1294 doi:10.1101/gad.585710.
39. Brown JP, Wei W, Sedivy JM, (1997) Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277: 831-834.
40. Sayama K, Shirakata Y, Midorikawa K, Hanakawa Y, Hashimoto K, (1999) Possible involvement of p21 but not of p16 or p53 in keratinocyte senescence. J Cell Physiol 179: 40-44 doi:10.1002/(SICI)1097-4652(199904)179:1&40::AID-JCP5>3.0.CO;2-Z.
41. de Keizer PLJ, Packer LM, Szypowska AA, Riedl-Polderman PE, van den Broek NJF, et al. (2010) Activation of Forkhead Box O Transcription Factors by Oncogenic BRAF Promotes p21cip1-Dependent Senescence. Cancer Res Available: http://www.ncbi.nlm.nih.gov/pubmed/20959475. Accessed 1 November 2010.
42. Borgdorff V, Lleonart ME, Bishop CL, Fessart D, Bergin AH, et al. (2010) Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21Waf1/Cip1. Oncogene 29: 2262-2271.
43. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92: 9363-9367.
44. Campisi J, (2010) Cellular senescence: putting the paradoxes in perspective. Curr Opin Genet Dev Available: http://www.ncbi.nlm.nih.gov/pubmed/21093253. Accessed 5 January 2011.
45. Collado M, Serrano M, (2010) Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 10: 51-57 doi:10.1038/nrc2772.
46. Krimpenfort P, Ijpenberg A, Song J-Y, van der Valk M, Nawijn M, et al. (2007) p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 448: 943-946 doi:10.1038/nature06084.
47. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, et al. (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557 doi:10.1038/377552a0.
48. Atanasoski S, Boller D, De Ventura L, Koegel H, Boentert M, et al. (2006) Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation. Glia 53: 147-157 doi:10.1002/glia.20263.
49. Boyd KE, Wells J, Gutman J, Bartley SM, Farnham PJ, (1998) c-Myc target gene specificity is determined by a post-DNAbinding mechanism. Proc Natl Acad Sci USA 95: 13887-13892.